Experiences with SARS-CoV-2 (Covid-19) in Trinidad and Tobago, a small island developing state: realities and opportunities.

COVID 19 Opportunities Trinidad and Tobago

Journal

Lancet regional health. Americas
ISSN: 2667-193X
Titre abrégé: Lancet Reg Health Am
Pays: England
ID NLM: 9918232503006676

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 26 04 2023
revised: 27 07 2023
accepted: 28 08 2023
medline: 20 9 2023
pubmed: 20 9 2023
entrez: 20 9 2023
Statut: epublish

Résumé

The COVID-19 pandemic has exerted significant global challenges that are expressed in a variety of socio-politico-economic scenarios, depending upon individual countries' preparedness and resilience. The impact COVID-19 in Small Island Developing States (SIDS), most of which are categorized as Lower and Middle-Income Countries, has been pronounced. Furthermore, many of these SIDS possess specific vulnerabilities to global threats. This paper contextualizes the experience of Trinidad and Tobago from some perspectives of geoeconomics, healthcare, and international relations. In many ways, the experience is similar to that of other SIDS with the inherent nuances of a post-colonial world. Trinidad and Tobago was ranked number one by the Oxford University COVID-19 Government Response Tracker (OxCGRT) "Lockdown rollback checklist: Do countries meet WHO recommendations for rolling back lockdown?". Despite the significant political support to combat the disease, by the end of 2022, the country had recorded over four thousand deaths and just over 50% of the population is vaccinated. This paper seeks to discuss the successes and challenges faced by this twin island state.

Identifiants

pubmed: 37727866
doi: 10.1016/j.lana.2023.100589
pii: S2667-193X(23)00163-1
pmc: PMC10505969
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100589

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

None of the authors listed have any financial benefits from the development and publication of this manuscript.

Références

Lancet Reg Health Am. 2023 Mar;19:100440
pubmed: 36743346
BMJ Glob Health. 2021 Aug;6(8):
pubmed: 34433544
J Nurs Manag. 2021 Nov;29(8):2329-2342
pubmed: 34182609
Int J Epidemiol. 2017 Aug 1;46(4):1312-1318
pubmed: 28938756
Respirology. 2021 Nov;26(11):1082-1084
pubmed: 34431158
Am J Trop Med Hyg. 2020 Aug;103(2):590-592
pubmed: 32524961
PLoS One. 2021 Dec 22;16(12):e0258348
pubmed: 34936646
J Glob Health. 2021 Nov 13;11:03121
pubmed: 34804512

Auteurs

Darren Dookeeram (D)

Sangre Grande Hospital, Eastern Regional Health Authority, Trinidad and Tobago.
School of Pharmacy, The University of the West Indies, Trinidad and Tobago.

Seetharaman Hariharan (S)

School of Graduate Studies, The University of the West Indies, Trinidad and Tobago.

Ian Hambleton (I)

George Alleyne Chronic Disease Research Centre, Caribbean Institute for Health Research, The University of the West Indies, Barbados.
Faculty of Medical Sciences, The University of the West Indies, Trinidad and Tobago.

Kareema Ali (K)

Sangre Grande Hospital, Eastern Regional Health Authority, Trinidad and Tobago.

Surujpaul Teelucksingh (S)

Faculty of Medical Sciences, The University of the West Indies, Trinidad and Tobago.

Samuel Ramsewak (S)

Faculty of Medical Sciences, The University of the West Indies, Trinidad and Tobago.

Dave Dookeeram (D)

DispatchHealth, Denver, CO, USA.

Sandeep Bhupendra Maharaj (SB)

School of Pharmacy, The University of the West Indies, Trinidad and Tobago.
Planetary Health Alliance, Boston, MA, USA.

Classifications MeSH